Filing metadata

Accession number
0001567619-22-008867
Form type
Form 4
Filer
Enliven Therapeutics, Inc.
CIK
CIK 1672619
Filed
Apr 25, 2022
Reporting period
Apr 21, 2022
Description
Insider transaction

Explore SEC Filings Hub